English
简体中文
Total: £ 56.28
Published Date: 2026-04-02 | Pages: 120 | Tables: 121 | Medical Devices & Consumables
The global Implantable Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Implantable Heart Failure Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.
According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories: mechanical assistance, electrical-related technology and structural improvement. In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.
The North American market for Implantable Heart Failure Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Implantable Heart Failure Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Implantable Heart Failure Devices include Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Implantable Heart Failure Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Implantable Heart Failure Devices. The Implantable Heart Failure Devices market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Implantable Heart Failure Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Implantable Heart Failure Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott
Medtronic
Jarvik Heart
Abiomed
Boston Scientific
Impulse Dynamics
SynCardia
Berlin Heart
Covia Medica
V-Wave
Evaheart
BrioHealth Solutions
Hanyu Medical
NewMed Medical
Valgen Medtech
Segment by Type
Mechanical Assistance Type
Electrical Related Technology
Structural Improvement Type
by Application
GradeⅠ- Ⅳ
Grade Ⅱ- Ⅳ
Grade Ⅲ -IV
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Implantable Heart Failure Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Implantable Heart Failure Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Implantable Heart Failure Devices Market Overview
1.1 Product Definition
1.2 Implantable Heart Failure Devices by Type
1.2.1 Global Implantable Heart Failure Devices Market Value by Type: 2025 vs 2032
1.2.2 Mechanical Assistance Type
1.2.3 Electrical Related Technology
1.2.4 Structural Improvement Type
1.3 Implantable Heart Failure Devices by Application
1.3.1 Global Implantable Heart Failure Devices Market Value by Application: 2025 vs 2032
1.3.2 GradeⅠ- Ⅳ
1.3.3 Grade Ⅱ- Ⅳ
1.3.4 Grade Ⅲ -IV
1.4 Global Implantable Heart Failure Devices Market Size Estimates and Forecasts
1.4.1 Global Implantable Heart Failure Devices Revenue 2021–2032
1.4.2 Global Implantable Heart Failure Devices Sales 2021–2032
1.4.3 Global Implantable Heart Failure Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Implantable Heart Failure Devices Market Competition by Manufacturers
2.1 Global Implantable Heart Failure Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Implantable Heart Failure Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Implantable Heart Failure Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Implantable Heart Failure Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Implantable Heart Failure Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Implantable Heart Failure Devices, Product Types and Applications
2.7 Global Key Manufacturers of Implantable Heart Failure Devices, Date of Entry into the Industry
2.8 Global Implantable Heart Failure Devices Market Competitive Situation and Trends
2.8.1 Global Implantable Heart Failure Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Implantable Heart Failure Devices Players Market Share by Revenue
2.8.3 Global Implantable Heart Failure Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Implantable Heart Failure Devices Market Scenario by Region
3.1 Global Implantable Heart Failure Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Implantable Heart Failure Devices Sales by Region: 2021–2032
3.2.1 Global Implantable Heart Failure Devices Sales by Region: 2021–2026
3.2.2 Global Implantable Heart Failure Devices Sales by Region: 2027–2032
3.3 Global Implantable Heart Failure Devices Revenue by Region: 2021–2032
3.3.1 Global Implantable Heart Failure Devices Revenue by Region: 2021–2026
3.3.2 Global Implantable Heart Failure Devices Revenue by Region: 2027–2032
3.4 North America Implantable Heart Failure Devices Market Facts & Figures by Country
3.4.1 North America Implantable Heart Failure Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Implantable Heart Failure Devices Sales by Country (2021–2032)
3.4.3 North America Implantable Heart Failure Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Implantable Heart Failure Devices Market Facts & Figures by Country
3.5.1 Europe Implantable Heart Failure Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Implantable Heart Failure Devices Sales by Country (2021–2032)
3.5.3 Europe Implantable Heart Failure Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Heart Failure Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Implantable Heart Failure Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Implantable Heart Failure Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Implantable Heart Failure Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Implantable Heart Failure Devices Market Facts & Figures by Country
3.7.1 Latin America Implantable Heart Failure Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Implantable Heart Failure Devices Sales by Country (2021–2032)
3.7.3 Latin America Implantable Heart Failure Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Implantable Heart Failure Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Heart Failure Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Implantable Heart Failure Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Implantable Heart Failure Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Heart Failure Devices Sales by Type (2021–2032)
4.1.1 Global Implantable Heart Failure Devices Sales by Type (2021–2026)
4.1.2 Global Implantable Heart Failure Devices Sales by Type (2027–2032)
4.1.3 Global Implantable Heart Failure Devices Sales Market Share by Type (2021–2032)
4.2 Global Implantable Heart Failure Devices Revenue by Type (2021–2032)
4.2.1 Global Implantable Heart Failure Devices Revenue by Type (2021–2026)
4.2.2 Global Implantable Heart Failure Devices Revenue by Type (2027–2032)
4.2.3 Global Implantable Heart Failure Devices Revenue Market Share by Type (2021–2032)
4.3 Global Implantable Heart Failure Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Implantable Heart Failure Devices Sales by Application (2021–2032)
5.1.1 Global Implantable Heart Failure Devices Sales by Application (2021–2026)
5.1.2 Global Implantable Heart Failure Devices Sales by Application (2027–2032)
5.1.3 Global Implantable Heart Failure Devices Sales Market Share by Application (2021–2032)
5.2 Global Implantable Heart Failure Devices Revenue by Application (2021–2032)
5.2.1 Global Implantable Heart Failure Devices Revenue by Application (2021–2026)
5.2.2 Global Implantable Heart Failure Devices Revenue by Application (2027–2032)
5.2.3 Global Implantable Heart Failure Devices Revenue Market Share by Application (2021–2032)
5.3 Global Implantable Heart Failure Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Implantable Heart Failure Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic Implantable Heart Failure Devices Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Jarvik Heart
6.3.1 Jarvik Heart Company Information
6.3.2 Jarvik Heart Description and Business Overview
6.3.3 Jarvik Heart Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jarvik Heart Implantable Heart Failure Devices Product Portfolio
6.3.5 Jarvik Heart Recent Developments/Updates
6.4 Abiomed
6.4.1 Abiomed Company Information
6.4.2 Abiomed Description and Business Overview
6.4.3 Abiomed Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Abiomed Implantable Heart Failure Devices Product Portfolio
6.4.5 Abiomed Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Company Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Boston Scientific Implantable Heart Failure Devices Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Impulse Dynamics
6.6.1 Impulse Dynamics Company Information
6.6.2 Impulse Dynamics Description and Business Overview
6.6.3 Impulse Dynamics Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Impulse Dynamics Implantable Heart Failure Devices Product Portfolio
6.6.5 Impulse Dynamics Recent Developments/Updates
6.7 SynCardia
6.7.1 SynCardia Company Information
6.7.2 SynCardia Description and Business Overview
6.7.3 SynCardia Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 SynCardia Implantable Heart Failure Devices Product Portfolio
6.7.5 SynCardia Recent Developments/Updates
6.8 Berlin Heart
6.8.1 Berlin Heart Company Information
6.8.2 Berlin Heart Description and Business Overview
6.8.3 Berlin Heart Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Berlin Heart Implantable Heart Failure Devices Product Portfolio
6.8.5 Berlin Heart Recent Developments/Updates
6.9 Covia Medica
6.9.1 Covia Medica Company Information
6.9.2 Covia Medica Description and Business Overview
6.9.3 Covia Medica Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Covia Medica Implantable Heart Failure Devices Product Portfolio
6.9.5 Covia Medica Recent Developments/Updates
6.10 V-Wave
6.10.1 V-Wave Company Information
6.10.2 V-Wave Description and Business Overview
6.10.3 V-Wave Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 V-Wave Implantable Heart Failure Devices Product Portfolio
6.10.5 V-Wave Recent Developments/Updates
6.11 Evaheart
6.11.1 Evaheart Company Information
6.11.2 Evaheart Description and Business Overview
6.11.3 Evaheart Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Evaheart Implantable Heart Failure Devices Product Portfolio
6.11.5 Evaheart Recent Developments/Updates
6.12 BrioHealth Solutions
6.12.1 BrioHealth Solutions Company Information
6.12.2 BrioHealth Solutions Description and Business Overview
6.12.3 BrioHealth Solutions Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 BrioHealth Solutions Implantable Heart Failure Devices Product Portfolio
6.12.5 BrioHealth Solutions Recent Developments/Updates
6.13 Hanyu Medical
6.13.1 Hanyu Medical Company Information
6.13.2 Hanyu Medical Description and Business Overview
6.13.3 Hanyu Medical Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hanyu Medical Implantable Heart Failure Devices Product Portfolio
6.13.5 Hanyu Medical Recent Developments/Updates
6.14 NewMed Medical
6.14.1 NewMed Medical Company Information
6.14.2 NewMed Medical Description and Business Overview
6.14.3 NewMed Medical Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 NewMed Medical Implantable Heart Failure Devices Product Portfolio
6.14.5 NewMed Medical Recent Developments/Updates
6.15 Valgen Medtech
6.15.1 Valgen Medtech Company Information
6.15.2 Valgen Medtech Description and Business Overview
6.15.3 Valgen Medtech Implantable Heart Failure Devices Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Valgen Medtech Implantable Heart Failure Devices Product Portfolio
6.15.5 Valgen Medtech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Heart Failure Devices Industry Chain Analysis
7.2 Implantable Heart Failure Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Heart Failure Devices Production Mode & Process Analysis
7.4 Implantable Heart Failure Devices Sales and Marketing
7.4.1 Implantable Heart Failure Devices Sales Channels
7.4.2 Implantable Heart Failure Devices Distributors
7.5 Implantable Heart Failure Devices Customer Analysis
8 Implantable Heart Failure Devices Market Dynamics
8.1 Implantable Heart Failure Devices Industry Trends
8.2 Implantable Heart Failure Devices Market Drivers
8.3 Implantable Heart Failure Devices Market Challenges
8.4 Implantable Heart Failure Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Implantable Heart Failure Devices Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Implantable Heart Failure Devices Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Implantable Heart Failure Devices Market Competitive Situation by Manufacturers in 2025
Table 4. Global Implantable Heart Failure Devices Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Implantable Heart Failure Devices Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Implantable Heart Failure Devices Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Implantable Heart Failure Devices Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Implantable Heart Failure Devices Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Implantable Heart Failure Devices, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Implantable Heart Failure Devices, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Implantable Heart Failure Devices, Product Types and Applications
Table 12. Global Key Manufacturers of Implantable Heart Failure Devices, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Implantable Heart Failure Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Implantable Heart Failure Devices Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Implantable Heart Failure Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Implantable Heart Failure Devices Sales by Region (Units), 2021–2026
Table 18. Global Implantable Heart Failure Devices Sales Market Share by Region (2021–2026)
Table 19. Global Implantable Heart Failure Devices Sales by Region (Units), 2027–2032
Table 20. Global Implantable Heart Failure Devices Sales Market Share by Region (2027–2032)
Table 21. Global Implantable Heart Failure Devices Revenue by Region (US$ Million), 2021–2026
Table 22. Global Implantable Heart Failure Devices Revenue Market Share by Region (2021–2026)
Table 23. Global Implantable Heart Failure Devices Revenue by Region (US$ Million), 2027–2032
Table 24. Global Implantable Heart Failure Devices Revenue Market Share by Region (2027–2032)
Table 25. North America Implantable Heart Failure Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Implantable Heart Failure Devices Sales by Country (Units), 2021–2026
Table 27. North America Implantable Heart Failure Devices Sales by Country (Units), 2027–2032
Table 28. North America Implantable Heart Failure Devices Revenue by Country (US$ Million), 2021–2026
Table 29. North America Implantable Heart Failure Devices Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Implantable Heart Failure Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Implantable Heart Failure Devices Sales by Country (Units), 2021–2026
Table 32. Europe Implantable Heart Failure Devices Sales by Country (Units), 2027–2032
Table 33. Europe Implantable Heart Failure Devices Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Implantable Heart Failure Devices Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Implantable Heart Failure Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Implantable Heart Failure Devices Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Implantable Heart Failure Devices Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Implantable Heart Failure Devices Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Implantable Heart Failure Devices Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Implantable Heart Failure Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Implantable Heart Failure Devices Sales by Country (Units), 2021–2026
Table 42. Latin America Implantable Heart Failure Devices Sales by Country (Units), 2027–2032
Table 43. Latin America Implantable Heart Failure Devices Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Implantable Heart Failure Devices Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Implantable Heart Failure Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Implantable Heart Failure Devices Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Implantable Heart Failure Devices Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Implantable Heart Failure Devices Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Implantable Heart Failure Devices Revenue by Country (US$ Million), 2027–2032
Table 50. Global Implantable Heart Failure Devices Sales (Units) by Type (2021–2026)
Table 51. Global Implantable Heart Failure Devices Sales (Units) by Type (2027–2032)
Table 52. Global Implantable Heart Failure Devices Sales Market Share by Type (2021–2026)
Table 53. Global Implantable Heart Failure Devices Sales Market Share by Type (2027–2032)
Table 54. Global Implantable Heart Failure Devices Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Implantable Heart Failure Devices Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Implantable Heart Failure Devices Revenue Market Share by Type (2021–2026)
Table 57. Global Implantable Heart Failure Devices Revenue Market Share by Type (2027–2032)
Table 58. Global Implantable Heart Failure Devices Price (K US$/Unit) by Type (2021–2026)
Table 59. Global Implantable Heart Failure Devices Price (K US$/Unit) by Type (2027–2032)
Table 60. Global Implantable Heart Failure Devices Sales (Units) by Application (2021–2026)
Table 61. Global Implantable Heart Failure Devices Sales (Units) by Application (2027–2032)
Table 62. Global Implantable Heart Failure Devices Sales Market Share by Application (2021–2026)
Table 63. Global Implantable Heart Failure Devices Sales Market Share by Application (2027–2032)
Table 64. Global Implantable Heart Failure Devices Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Implantable Heart Failure Devices Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Implantable Heart Failure Devices Revenue Market Share by Application (2021–2026)
Table 67. Global Implantable Heart Failure Devices Revenue Market Share by Application (2027–2032)
Table 68. Global Implantable Heart Failure Devices Price (K US$/Unit) by Application (2021–2026)
Table 69. Global Implantable Heart Failure Devices Price (K US$/Unit) by Application (2027–2032)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 73. Abbott Implantable Heart Failure Devices Product
Table 74. Abbott Recent Developments/Updates
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 78. Medtronic Implantable Heart Failure Devices Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Jarvik Heart Company Information
Table 81. Jarvik Heart Description and Business Overview
Table 82. Jarvik Heart Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 83. Jarvik Heart Implantable Heart Failure Devices Product
Table 84. Jarvik Heart Recent Developments/Updates
Table 85. Abiomed Company Information
Table 86. Abiomed Description and Business Overview
Table 87. Abiomed Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 88. Abiomed Implantable Heart Failure Devices Product
Table 89. Abiomed Recent Developments/Updates
Table 90. Boston Scientific Company Information
Table 91. Boston Scientific Description and Business Overview
Table 92. Boston Scientific Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 93. Boston Scientific Implantable Heart Failure Devices Product
Table 94. Boston Scientific Recent Developments/Updates
Table 95. Impulse Dynamics Company Information
Table 96. Impulse Dynamics Description and Business Overview
Table 97. Impulse Dynamics Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 98. Impulse Dynamics Implantable Heart Failure Devices Product
Table 99. Impulse Dynamics Recent Developments/Updates
Table 100. SynCardia Company Information
Table 101. SynCardia Description and Business Overview
Table 102. SynCardia Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 103. SynCardia Implantable Heart Failure Devices Product
Table 104. SynCardia Recent Developments/Updates
Table 105. Berlin Heart Company Information
Table 106. Berlin Heart Description and Business Overview
Table 107. Berlin Heart Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 108. Berlin Heart Implantable Heart Failure Devices Product
Table 109. Berlin Heart Recent Developments/Updates
Table 110. Covia Medica Company Information
Table 111. Covia Medica Description and Business Overview
Table 112. Covia Medica Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 113. Covia Medica Implantable Heart Failure Devices Product
Table 114. Covia Medica Recent Developments/Updates
Table 115. V-Wave Company Information
Table 116. V-Wave Description and Business Overview
Table 117. V-Wave Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 118. V-Wave Implantable Heart Failure Devices Product
Table 119. V-Wave Recent Developments/Updates
Table 120. Evaheart Company Information
Table 121. Evaheart Description and Business Overview
Table 122. Evaheart Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 123. Evaheart Implantable Heart Failure Devices Product
Table 124. Evaheart Recent Developments/Updates
Table 125. BrioHealth Solutions Company Information
Table 126. BrioHealth Solutions Description and Business Overview
Table 127. BrioHealth Solutions Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 128. BrioHealth Solutions Implantable Heart Failure Devices Product
Table 129. BrioHealth Solutions Recent Developments/Updates
Table 130. Hanyu Medical Company Information
Table 131. Hanyu Medical Description and Business Overview
Table 132. Hanyu Medical Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 133. Hanyu Medical Implantable Heart Failure Devices Product
Table 134. Hanyu Medical Recent Developments/Updates
Table 135. NewMed Medical Company Information
Table 136. NewMed Medical Description and Business Overview
Table 137. NewMed Medical Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 138. NewMed Medical Implantable Heart Failure Devices Product
Table 139. NewMed Medical Recent Developments/Updates
Table 140. Valgen Medtech Company Information
Table 141. Valgen Medtech Description and Business Overview
Table 142. Valgen Medtech Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 143. Valgen Medtech Implantable Heart Failure Devices Product
Table 144. Valgen Medtech Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Implantable Heart Failure Devices Distributors List
Table 148. Implantable Heart Failure Devices Customers List
Table 149. Implantable Heart Failure Devices Market Trends
Table 150. Implantable Heart Failure Devices Market Drivers
Table 151. Implantable Heart Failure Devices Market Challenges
Table 152. Implantable Heart Failure Devices Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Implantable Heart Failure Devices
Figure 2. Global Implantable Heart Failure Devices Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Implantable Heart Failure Devices Market Share by Type: 2025 & 2032
Figure 4. Mechanical Assistance Type Product Picture
Figure 5. Electrical Related Technology Product Picture
Figure 6. Structural Improvement Type Product Picture
Figure 7. Global Implantable Heart Failure Devices Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Implantable Heart Failure Devices Market Share by Application: 2025 & 2032
Figure 9. GradeⅠ- Ⅳ
Figure 10. Grade Ⅱ- Ⅳ
Figure 11. Grade Ⅲ -IV
Figure 12. Global Implantable Heart Failure Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Implantable Heart Failure Devices Market Size (US$ Million), 2021–2032
Figure 14. Global Implantable Heart Failure Devices Sales (Units), 2021–2032
Figure 15. Global Implantable Heart Failure Devices Average Price (K US$/Unit), 2021–2032
Figure 16. Implantable Heart Failure Devices Report Years Considered
Figure 17. Implantable Heart Failure Devices Sales Share by Manufacturers in 2025
Figure 18. Global Implantable Heart Failure Devices Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Implantable Heart Failure Devices Players: Market Share by Revenue in Implantable Heart Failure Devices in 2025
Figure 20. Implantable Heart Failure Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Implantable Heart Failure Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Implantable Heart Failure Devices Sales Market Share by Country (2021–2032)
Figure 23. North America Implantable Heart Failure Devices Revenue Market Share by Country (2021–2032)
Figure 24. United States Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Implantable Heart Failure Devices Sales Market Share by Country (2021–2032)
Figure 27. Europe Implantable Heart Failure Devices Revenue Market Share by Country (2021–2032)
Figure 28. Germany Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Implantable Heart Failure Devices Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Implantable Heart Failure Devices Revenue Market Share by Region (2021–2032)
Figure 35. China Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Implantable Heart Failure Devices Sales Market Share by Country (2021–2032)
Figure 43. Latin America Implantable Heart Failure Devices Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Implantable Heart Failure Devices Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Implantable Heart Failure Devices Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Implantable Heart Failure Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Implantable Heart Failure Devices by Type (2021–2032)
Figure 54. Global Revenue Market Share of Implantable Heart Failure Devices by Type (2021–2032)
Figure 55. Global Implantable Heart Failure Devices Price (K US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Implantable Heart Failure Devices by Application (2021–2032)
Figure 57. Global Revenue Market Share of Implantable Heart Failure Devices by Application (2021–2032)
Figure 58. Global Implantable Heart Failure Devices Price (K US$/Unit) by Application (2021–2032)
Figure 59. Implantable Heart Failure Devices Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
